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The relationship among nephrin, podocin, CD2AP,
and a-actinin might not be a true ‘interaction’
in podocyte
Q Fan1,2, Y Xing1,2, J Ding1, N Guan1 and J Zhang1
1Department of Pediatrics, Peking University First Hospital, Beijing, Peoples Republic of China
The abnormality of a single podocyte molecule, caused by a
single gene mutation, such as NPHS1, NPHS2, CD2AP, and
ACTN4, can lead to the hereditary/congenital nephrotic
syndromes (NS). Further studies suggested that more than
one podocyte molecule were together involved in acquired
or experimental NS. However, we do not know much on the
relationship among these podocyte molecules, and the
molecular response induced by the change of each podocyte
protein to the remaining ones. We respectively knockdown
the nephrin, podocin, CD2AP, or a-actinin-4 mRNA by using
reconstructed RNA interference vector – psiRNA-hH1GFPzeo
in mouse podocyte clone. The molecular behavior or
response was revealed by the quantitative expression both at
mRNA and protein levels with RT-PCR and Western blot, and
by the molecular distribution detected with confocal
microscopy. With nephrin knockdown, only CD2AP increased,
whereas podocin showed no change. Contrarily, with
podocin or CD2AP knockdown, nephrin decreased, while
CD2AP or podocin increased. Nephrin, podocin, or CD2AP
knockdown did not change the expression of a-actinin-4,
whereas a-actinin-4 knockdown begetted the reduction of
nephrin, and the increment of podocin and CD2AP. The
redistributions of nephrin, podocin, and CD2AP were
revealed around a predominant nuclear staining compared
with the membrane surface staining in the control
podocytes. Our data imply that the response between the
four podocyte molecules is very complicated and evidently
different. There is not always an interaction between
podocyte molecules. The normal localization of podocyte
molecules would depend on their normal expression
quantity and the molecular reactions between them.
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Podocytes are highly terminally differentiated cells with
major processes and foot processes interlinked by ultrathin
slit diaphragms (SD). The SD may represent a modified
adhesion junction and is primarily responsible for the size
selectivity of the glomerular filter.1,2 However, the molecular
components of the SD complex are still poorly understood
for many years. Recently, the identification of several novel
podocyte molecules and the description of their physical and
functional interactions brought new insights into the
components of the SD complex and the regulation of the
glomerular filtration barrier. Nephrin, encoded by NPHS1,
the gene mutated in congenital nephrotic syndrome (NS) of
the Finnish type, has been suggested to form the SD by either
homo- or heterophilic interactions.3 Two other genes
involved in proteinuria have also been identified. Of them,
NPHS2, the causative gene for autosomal recessive steroid-
resistant NS, encodes an integral membrane-associated
protein, podocin, which is proposed to function as a
scaffolding protein and capable of modulating nephrin-
signaling activity.4,5 The other gene, ACTN4, has been shown
to cause hereditary familial focal segmental glomerulosclero-
sis, and encodes an actin-filament cross-linking protein, a-
actinin-4.6 In addition, the mice completely knockout of the
gene CD2AP encoding CD2-assosiated protein (CD2AP),
which localizes to the cytoplasmic face of the SD, develop the
congenital NS and die of the massive proteinuria soon after
birth.7 Moreover, NEPH1, another IgG superfamily protein,8
and FAT, the member of the protocadherin superfamily
proteins,9 and P-cadherin2 have been shown to localize to the
SD. Targeted deletion of the FAT or NEPH1 gene in mice also
leads to NS.8,9 These studies suggested that these podocyte
proteins play an essential role in maintaining the structural
and functional integrity of the glomerular filtration barrier.
A single gene mutation, such as NPHS1, NPHS2, and
ACTN4, can lead to the hereditary or familial NS, implying
that the abnormality of a single podocyte molecule caused by
a single gene mutation, might be enough to induce NS.
Further studies from acquired NS10–14 and experimental
NS15–18 suggested that many podocyte molecules were
together involved in maintaining the structural and func-
tional integrity of the SD. Although we are starting to
understand the role of podocyte molecule from the view of a
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single molecule, we do not know much on the relationship
among these molecules in maintaining the integrity of the SD
and in the occurrence and development of proteinuria, and
we also do not know much on the molecular effects caused by
the change of each podocyte proteins on the remaining ones.
So, it is necessary to explore the function of a single podocyte
molecule, especially the three important proteins nephrin,
podocin, and CD2AP, and the cytoskeletal protein a-actinin-
4, in order to discover the potential sites or molecular
target(s) for the intervention of proteinuria.
In this study, we investigated the molecular behavior or
response by the respective knockdown (KD) of nephrin,
podocin, CD2AP, or a-actinin-4 mRNA in mouse podocyte
clone 519 with a novel gene block technique – RNA
interference (RNAi), which is widely used to eliminate gene
activity by degrading the specific mRNAs with complemen-
tary sequence.20
RESULTS
Immunofluorescence staining
In control group, the staining for podocin and nephrin
distributed in perinuclear and mainly on the cell membrane
surface in a filamentous pattern. CD2AP was evenly localized
in the cytoplasm and on the cell membrane surface. The a-
actinin staining pattern was different from that of podocin,
nephrin, and CD2AP. a-Actinin mainly distributed in the
cytoplasm in a filamentous pattern and also extended to the
podocyte processes (Figure 1).
In podocin KD group (siPod 966 and siPod 54), the
intensities of podocin and nephrin were distinctly lower than
those in control, and the staining for them was localized
predominantly around nuclei with a loss of surface distribu-
tion. The intensity of CD2AP increased significantly, and its
staining mainly distributed around nuclei with a normal
membrane expression. However, the intensity and distribu-
tion of a-actinin did not change (Figure 2).
In nephrin KD group (siNep 492), the changes of the
intensities and distributions of nephrin and CD2AP were the
same as those in podocin KD group, whereas that of podocin
and a-actinin did not change (Figure 3). In siNep 1031
group, the intensities and distributions of nephrin, podocin,
CD2AP, and a-actinin showed no change (data not shown).
In CD2AP KD group (siCda 744 and siCda 21), the
intensities of CD2AP and nephrin were obviously lower than
those in control, and the staining for them predominantly
distributed around nuclei with a loss of surface expression.
Compared with control, the intensity of podocin was
distinctly higher, and its staining was mainly localized
around nuclei with the normal expression of the cytoplasm
and the membrane. No change was observed for a-actinin
(Figure 4).
In a-actinin-4 KD group (siAct 1790 and siAct 319), the
intensity of a-actinin was distinctly lower with normal
distribution. All other proteins changed with distribution
and expression alteration, that is, nephrin decreased with a
loss of surface expression, whereas the perinuclear staining
for podocin and CD2AP increased evidently with a normal
expression of the membrane surface (Figure 5).
Semiquantitative reverse transcriptase-PCR
The specific DNA bands of podocin, nephrin, CD2AP, a-
actinin-4, and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) were observed with the size of 193, 211, 191,
277, and 201 bp, respectively, and the quantitative results in
relation to GAPDH at mRNA level were shown in Table 1 and
Figure 6.
Western blotting
The specific protein bands of podocin, nephrin, CD2AP, a-
actinin, and GAPDH were detected with the size of 44, 180,
80, 100, and 36 kDa, respectively, and the quantitative results
at protein level in relation to GAPDH were shown in Table 2
and Figure 7.
DISCUSSION
The massive proteinuria is the most important clinical
manifestation of NS. The SD plays a crucial role in preventing
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Figure 1 | Expressions of podocin, nephrin, a-actinin, and CD2AP
in mouse podocytes transfected with control RNA interference
vector. (a, e, i, and m) The nuclei were stained in blue with Hoechst .
(b, f, j, and n) The podocytes transfected with control RNA
interference vector were indicated in green with green fluorescence
protein and (c, g, k, and o) marked by the arrowhead. (c, g, k, and o)
The expressions of podocin, nephrin, a-actinin, and CD2AP were
shown in red, respectively, in which arrows indicate the podocytes
not transfected with control RNA interference vector. (d, h, l, and p)
The merged photos from a–c, e–g, i–k, and m–o, respectively. Both
in the transfected cells and the non-transfected cells, podocin (c) and
nephrin (g) all showed a perinuclear and mainly continuous
membrane staining pattern, a-actinin (k) showed a cytoplasmic
filamentous staining extending to the processes, and CD2AP (o) was
weakly diffuse in the cytoplasm and on the membrane. Bar¼ 50mm.
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proteins and other larger molecules from leaking to urine.1,2
Recently, exciting studies demonstrated that the SD complex
contains at least three important proteins: nephrin, podocin,
and CD2AP, the genes mutated leading to congenital or
familial NS.3,5,7 Moreover, further in vitro studies suggested
that there might be some interactions among these podocyte
molecules. Schwarz et al.21 revealed that podocin might
recruit nephrin and connect via its C-terminal domain with
CD2AP. Studies from Huber’s group showed that nephrin-
induced signaling could be greatly enhanced by podocin in
HEK 293 cells.5 In addition, Saleem et al.22 found that
nephrin and podocin might partially colocalize with actin
filaments, and might be dependent on integral actin polymers
for their intracellular distribution in podocyte.
Simultaneously, studies from some congenital/hereditary
and acquired NS implied that the expression or distribution
abnormality of a single or many podocyte molecule(s) can
lead to the abnormalities of the SD structure and proteinuria.
For example, nephrin and podocin decreased evidently at
protein level in some NS patients with minimal change
nephropathy, focal segmental glomerulosclerosis, lupus
nephritis, or diabetic nephropathy,12 and the remarkable
redistributions of nephrin, podocin, CD2AP, and a-actinin-4
were revealed in the NS patients with NPHS2 mutations,14
and in puromycin aminonucleoside nephrosis rat, the
expressions of nephrin and podocin decreased along with
an obvious redistribution of podocin before the occurrence
of proteinuria.15 These data highlighted the critical role of the
SD complex and the actin cytoskeleton in the maintenance of
the glomerular filtration barrier, and implied that these
molecules were together involved in the occurrence and
development of proteinuria. However, the molecular beha-
vior or response induced by the change of a single podocyte
molecule has not been completely elucidated. Therefore, it is
necessary to clarify the molecular interaction(s) among the
podocyte molecules, which is crucial to understand the
molecular mechanism of proteinuria and further discover
the potential molecular target(s) for the intervention of
proteinuria.
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Figure 2 | Expressions of podocin, nephrin, a-actinin and CD2AP
in mouse podocytes with the podocin knockdown (siPod 54).
(a, e, i, and m) The nuclei were stained in blue with Hoechst. (b, f, j,
and n) The podocytes transfected with siPod 54 were indicated in
green with green fluorescence protein and (c, g, k, and o) marked by
the arrowhead. (c, g, k, and o) The expressions of podocin, nephrin, a-
actinin and CD2AP were shown in red, respectively, in which arrows
indicate the podocytes not transfected with siPod 54. (d, h, l, and p)
The merged photos from a–c, e–g, i–k, and m–o, respectively. In the
transfected podocytes with the podocin knockdown, the membrane
surface staining of podocin and nephrin (arrowheads of c and g)
decreased evidently, whereas the perinuclear expression of CD2AP
(arrowhead of o) increased significantly with a normal membrane
staining, and the staining of a-actinin (arrowhead of k) still showed a
cytoplasmic filamentous staining extending to the processes as
indicated with arrow in k and described in Figure 2k. Bar¼ 50 mm.
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Figure 3 | Expressions of nephrin, podocin, CD2AP, and a-actinin
in mouse podocytes with the nephrin knockdown (siNep 492).
(a, e, i, and m) The nuclei were stained in blue with Hoechst. (b, f, j,
and n) The podocytes transfected with siNep 492 were indicated in
green with green fluorescence protein and (c, g, k, and o) marked by
the arrowhead. (c, g, k, and o) The expressions of nephrin, podocin, a-
actinin and CD2AP were shown in red, respectively, in which arrows
indicate the podocytes not transfected with siNep 492. (d, h, l, and p)
The merged photos from a–c, e–g, i–k, and m–o, respectively. In the
podocytes with the nephrin knockdown, the membrane staining for
nephrin (arrowheads of c) decreased evidently, whereas the peri-
nuclear expression of CD2AP (arrowhead of o) increased significantly
with a normal membrane staining. The staining for podocin
(arrowhead of g) still showed a perinuclear and mainly continuous
membrane staining pattern as indicated with arrow in g and
described in Figure 3g, and a-actinin (arrowheads of k) showed a
cytoplasmic filamentous staining extending to the processes as
indicated with arrow in k and described in Figure 3k. Bar¼ 50mm.
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RNAi can rapidly and specifically degrade the target
mRNA by generating an active RNA-induced silencing
complex, and is also termed as gene KD compared with
gene knockout (KO).20,23,24 Recently, studies have shown that
21-nucleotide hairpin siRNA duplexes can efficiently and
specifically inhibit the expressions of cognate genes in
mammalian cells, and that RNAi technique can be widely
used to study the gene function and to identify interacting
pairs of genes in a rapid and an inexpensive way.25–27 So, we
designed and reconstructed two recombinant RNAi vectors
targeted to the 50 and 30-terminal of the coding sequences of
nephrin, podocin, CD2AP, or a-actinin-4 mRNA, respec-
tively, to study the effect of the KD molecule on the
remaining non-KD ones and the molecular relationship
among these podocyte molecules. Our results showed that all
interference target sites except the siNep 1031 significantly led
to the corresponding gene silencing, but the efficacy of
individual RNAi was different. The RNAi efficacy of siPod
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Figure 4 | Expressions of CD2AP, podocin, nephrin, and a-actinin
in mouse podocytes with the CD2AP knockdown (siCda 21). (a, e,
i, and m) The nuclei were stained in blue with Hoechst. (b, f, j, and n)
The podocytes transfected with siCda 21 were indicated in green
with green fluorescence protein and (c, g, k, and o) marked by the
arrowhead. (c, g, k, and o) The expressions of CD2AP, podocin,
nephrin, and a-actinin were shown in red, respectively, in which
arrows indicate the podocytes not transfected with siCda 21. (d, h, l,
and p) The merged photos from a–c, e–g, i–k, and m–o, respectively.
In the podocytes with the CD2AP knockdown, the surface expres-
sions of CD2AP (arrowhead of c) and nephrin (arrowhead of k)
decreased obviously and was predominantly localized around nuclei,
whereas the perinuclear intensity of podocin (arrowhead of g)
increased distinctly with a normal membrane distribution, and a-
actinin (arrowhead of k) showed a cytoplasmic filamentous staining
extending to the processes as indicated with arrow in o and
described in Figure 4o. Bar¼ 50mm.
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Figure 5 | Expressions of a-actinin, podocin, nephrin, and CD2AP
in mouse podocytes with a-actinin-4 knockdown (siAct 1790). (a,
e, i, and m) The nuclei were stained in blue with Hoechst. (b, f, j, and
n) The podocytes transfected with siAct 1790 were indicated in green
with green fluorescence protein and (c, g, k, and o) marked by the
arrowhead. (c, g, k, and o) The expressions of a-actinin, podocin,
nephrin, and CD2AP were shown in red, respectively, in which arrows
indicate the podocytes not transfected with siAct 1790. (d, h, l, and p)
The merged photos from a–c, e–g, i–k, and m–o, respectively. In the
podocytes with a-actinin-4 knockdown, the staining for a-actinin
(arrowhead of c) was weak and diffusely distributed in the cytoplasm
and extending processes in a filamentous pattern, and the
membrane expression of nephrin (arrowhead of k) decreased
obviously and was predominantly localized around nuclei, whereas
the perinuclear stainings for podocin (arrowhead of g) and CD2AP
(arrowheads of o) distinctly increased with a normal membrane
distribution. Bar¼ 50 mm.
Table 1 | The mRNA quantification results of podocin, nephrin, a-actinin-4, and CD2AP in relation to GAPDH
siPod 966 siPod 54 siNep 1031 siNep 492 siAct 319 siAct 1790 siCda 744 siCda 21 Control
Podocin 0.1670.09* 0.2070.10* 0.6770.04 0.6870.14 0.8670.16 1.1270.23* 1.0070.16* 0.7070.08 0.6670.08
Nephrin 0.1470.06* 0.1870.05* 1.0370.29 0.1470.07* 0.4870.11* 0.3370.08* 0.5270.16* 0.5970.13* 1.0370.15
a-Actinin-4 1.1070.22 1.0970.15 1.0970.19 1.1270.25 0.4170.13* 0.3170.16* 1.1270.18 1.1070.17 1.0670.34
CD2AP 1.2470.16* 1.2170.15* 0.8470.10 1.1170.15* 1.0370.28 1.2370.20* 0.1570.05* 0.2470.13* 0.7870.04
The quantification of mRNA was carried out by detecting the band intensity of PCR products revealed by agarose gel electrophoresis. The data in the table are the
means7s.d. of the ratios between podocin, nephrin, CD2AP, a-actinin-4, and the corresponding GAPDH from four independent RNA interference experiments. *Statistical
significance relative to control, Po0.05.
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966, siAct 1790, and siCda 744 was obviously higher than
that of siPod 54, siAct 319, and siCda 21. This phenomenon
may be related to the location and secondary structure of the
interference target sites. Moreover, the different degree
changes of podocin and/or CD2AP were induced by the
different RNAi efficacy of the two target sites for a-actinin-4
or CD2AP. That is, the expression increments of podocin and
CD2AP were much more obvious in siAct 1790 group than in
siAct 319 group because the RNAi efficacy in siAct 1790
group was higher than that in siAct 319 group. Similarly, the
expression increment of podocin was much more significant
in siCda 744 group than in siCda 21 group because the RNAi
efficacy in siCda 744 group was higher than that in siCda 21
group.
With the nephrin KD, only the quantitative expression of
CD2AP increased, whereas podocin and a-actinin-4 showed
no change. Contrarily, the quantitative expressions of
nephrin all significantly decreased and its distributions
changed evidently with the podocin, CD2AP, or a-actinin-4
KD. Previously, we also observed the reduction of nephrin
with the podocin KD.28 Data from Hamano et al.29 showed
that the expressions and distributions of podocin, CD2AP,
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Figure 6 | Expressions of podocin, nephrin, a-actinin-4, CD2AP, and GAPDH at the mRNA level with the knockdown of podocin,
nephrin, a-actinin-4, or CD2AP mRNA, respectively. (a) The mRNA of podocin decreased significantly with the podocin knockdown (76% in
siPod 966 group and 70% in siPod 54 group), while increased significantly with the a-actinin-4 knockdown (70% in siAct 1790 group) and
CD2AP knockdown (52% in siCda 744 group). (b) The mRNA of nephrin decreased significantly with the nephrin knockdown (86% in siNep 492
group). Nephrin mRNA also decreased significantly with the podocin knockdown (86% in siPod 966 group and 83% in siPod 54 group),
a-actinin-4 knockdown (53% in siAct 319 group and 68% in siAct 1790 group) and CD2AP knockdown (50% in siCda 744 group and 43% in
siCda 21 group). (c) The mRNA of CD2AP decreased significantly with the CD2AP knockdown (81% in siCda 744 group and 69% in siCda 21
group), whereas increased significantly with the podocin knockdown (59% in siPod 966 group and 55% in siPod 54 group), nephrin knockdown
(42% in siNep 492 group) and a-actinin-4 knockdown (58% in siAct 1790 group). (d) The mRNA of a-actinin-4 decreased significantly with the
a-actinin-4 knockdown (61% in siAct 319 group and 71% in siAct 1790 group). Compared with control, a-actinin-4 mRNA did not change with
podocin, nephrin, or CD2AP knockdown. *Po0.05 vs the control.
Table 2 | The protein quantification results of nephrin, podocin, CD2AP, and a-actinin in relation to GAPDH
siPod 966 siPod 54 siNep 1031 siNep 492 siAct 319 siAct 1790 siCda 744 siCda 21 Control
Podocin 0.0570.03* 0.1070.05* 0.5270.16 0.4770.12 0.5370.07 0.7070.08* 0.6670.07* 0.5270.06 0.4470.07
Nephrin 0.2070.05* 0.3370.11* 1.1570.17 0.0570.03* 0.3870.10* 0.2970.10* 0.2870.07* 0.5970.35* 1.1270.10
a-Actinin-4 1.4570.29 1.5570.23 1.4870.17 1.4770.07 0.6370.12* 0.2870.10* 1.4470.08 1.5070.10 1.5070.12
CD2AP 0.9370.27* 0.9170.20* 0.5370.13 0.7570.12* 0.6970.08 1.0370.20* 0.0570.01* 0.1270.04* 0.5870.08
The quantification of protein expression was carried out by detecting the intensity of the Western blotting bands. The data in the table are the means7s.d. of the ratios
between podocin, nephrin, CD2AP, a-actinin-4, and the corresponding GAPDH from four independent RNA interference experiments.
*Statistical significance relative to control, Po0.05.
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and a-actinin-4 did not change in NPHS1 KO mice with the
obvious absence of the SD and podocyte effacement. In other
words, nephrin deficiency did not cause alterations in the
expression of podocin, CD2AP, and a-actinin-4, and only
nephrin abnormality might be enough to induce the change
of the SD structure and proteinuria. So, the role of nephrin
might be more important than podocin, CD2AP, and a-
actinin-4 on maintaining the normal structure and function
of the SD and in turn the proper function of the glomerular
filter compared to other podocyte molecules.
With the podocin, nephrin, CD2AP, or a-actinin-4 KD,
not only did the quantity of the affected non-KD molecules
change, but also their redistributions were observed from the
membrane surface to the predominant perinuclear. For
example, no matter the expressions decreased (because of
KD) or increased (caused by a-actinin-4 KD), the stainings
for podocin and CD2AP all disappeared in the membrane
surface along with the loss of nephrin in the cell surface.
Therefore, we postulate that the existence of podocin or
CD2AP might be very important and necessary for anchoring
nephrin to the membrane surface, and the mechanisms
underlying this should be further explored. Interestingly,
such reduction of nephrin and increment of CD2AP and
their redistributions were reported in the podocin-deficient
mice,30 and the changes in the distribution of nephrin,
CD2AP, and a-actinin-4 were observed in the NS patients
with NPHS2 mutations, which resulted in profound altera-
tion of podocin distribution restricted to the podocyte
body,14 and a small fraction of glomeruli had lost the
reactivity with the nephrin antibody in the CD2AP KO
mice.31 So, the normal localization of podocyte molecules
might depend on their normal expression quantity and the
normal molecular reactions among these molecules, which is
very critical for maintaining the normal podocyte biology
behaviors.
On the other hand, the behavior of a-actinin-4 showed no
change with the podocin, nephrin, or CD2AP KD, that is to
say, the KD of any SD complex molecule did not induce the
abnormality of a-actinin-4. Contrarily, the a-actinin-4 KD
evidently changed the expressions and distributions of
nephrin, podocin, and CD2AP. Namely, nephrin decreased
with the a-actinin-4 KD, whereas podocin and CD2AP
increased. Similarly, Michaud et al.13 detected the reduction
of nephrin mRNA in the ACTN4 mutant mice. Our results
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Figure 7 | Expressions of podocin, nephrin, a-actinin, CD2AP, and GAPDH at the protein level with the knockdown of podocin, nephrin,
a-actinin-4, or CD2AP mRNA, respectively. (a) The protein expression of podocin decreased significantly with the podocin knockdown (89%
in siPod 966 group and 77% in siPod 54 group), while increased significantly with the a-actinin-4 knockdown (59% in siAct 1790 group) and
CD2AP knockdown (50% in siCda 744 group). (b) The protein expression of nephrin decreased significantly with the nephrin knockdown (96%
in siNep 492 group), podocin knockdown (82% in siPod 966 group and 71% in siPod 54 group), a-actinin-4 knockdown (74% in siAct 1790
group and 66% in siAct 319 group) and CD2AP knockdown (75% in siCda 744 group and 47% in siCda 21 group). (c) The protein expression of
CD2AP decreased significantly with the CD2AP knockdown (91% in siCda 744 group and 79% in siCda 21 group), whereas increased
significantly with the podocin knockdown (60% in siPod 966 group and 57% in siPod 54 group), nephrin knockdown (29% in siNep 492 group)
and a-actinin-4 knockdown (78% in siAct 1790 group). (d) The protein expression of a-actinin-4 decreased significantly with the a-actinin-4
knockdown (81% in siAct 1790 group and 58% in siAct 319 group). Compared with control, a-actinin-4 did not change with podocin, nephrin,
or CD2AP knockdown. *Po0.05 vs control.
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imply that there might be a chain reaction between nephrin,
podocin, CD2AP, and a-actinin-4, and that a-actinin-4 might
directly or indirectly interact with nephrin, podocin, or
CD2AP. So, a-actinin-4 might also play an important role in
maintaining the structural and functional integrity of the SD,
and its abnormality might indirectly affect the expression of
the SD complex critical protein nephrin via podocin or
CD2AP. However, the role and significance of the increment
of podocin or CD2AP with the a-actinin-4 KD is still unclear,
and a compensative increment should be considered for the
reduction of nephrin in the membrane surface.
It is also worth noticing that some results from gene KO
were contrary to those from gene KD. Kos et al.32 found that
the expressions and distributions of nephrin and podocin did
not change in the ACTN4 KO mice, and Hamano et al.29 and
Rantanen et al.33 observed that the expression and distribu-
tion of CD2AP showed no change in the NPHS1 KO mice.
The phenomena may be induced by the different biology
effect between the complete gene deficiency caused by the
gene KO and the gene expression reduction caused by the
gene KD. In many diseases, the gene expression is often
reduction but not complete deficiency. So, the change of
molecular expression, distribution and reaction induced by
the gene KD compared with the gene KO, seems to be much
closer to the real in vivo situations. Additionally, our KD
experiments indicate that the expression of the KD molecule
decreased both at mRNA and protein level, which suggests
that RNAi is a post-transcriptional regulation that specifically
degrades the target mRNA. Furthermore, the change of the
remaining affected non-KD molecules at mRNA level is
consistent with that at protein level. For example, the nephrin
KD increased the expression of CD2AP not only at protein
level but also at mRNA level. This phenomenon suggests that
there might be an underlying mechanism by which the
reduction of the KD molecule at mRNA level causes the
mRNA and protein change of the affected non-KD
molecules.
In addition, there is another very interesting finding in the
podocyte molecular KD experiments. The relationship
among these podocyte molecules might not be a true
‘interaction.’ Our study shows that the nephrin or podocin
KD could increase CD2AP expression, in turn, the CD2AP
KD could decrease nephrin and increase podocin expression.
Nevertheless, the nephrin KD did not change the expression
of podocin, whereas the podocin KD decreased the expres-
sion of nephrin. A similar phenomenon was also found
between nephrin, podocin, or CD2AP and a-actinin-4.
Namely, there was no change on the a-actinin-4 expression
after the nephrin, podocin, or CD2AP KD, whereas the a-
actinin-4 KD begetted the reduction of nephrin, and the
increment of podocin and CD2AP, respectively. All of these
imply that the response between the four podocyte molecules
is very complicated and evidently different. Further under-
standing the relationship and interaction of these podocyte
molecules will help us to identify the critical molecular
target(s) in intervening the proteinuria, and some experi-
ments about the co-immunoprecipitation and signal trans-
duction pathway should be done in vivo in the future to
elucidate the response of these important molecules in the
occurrence and development of proteinuria.
Taken together, we successfully silenced the expressions of
nephrin, podocin, CD2AP, and a-actinin-4 with RNAi
technique, respectively. Our data suggest that the response
between the four podocyte molecules is very complicated and
evidently different. There is not always an interaction
between podocyte molecules. Moreover, the normal localiza-
tion of podocyte molecules would depend on their normal
expression quantity and the molecular reaction between
them.
MATERIALS AND METHODS
Design of small interference RNA (siRNA)
The mRNA sequences of the mouse NPHS1, NPHS2, CD2AP and
ACTN4 gene were obtained from the GenBank (accession number
AF191090, NM130456, NM009847, and NM021895, respectively).
The coding sequences of mRNA were searched for the interference
target sites. The potential targets were the oligonucleotides starting
with A or G as the transcription initiation point of hH1 promoter
followed by 20 nucleotides, in which a stretch of more than four Ts
as the terminal signal for RNA polIII, or a set of six G and C or T
(e.g., GCCGGC or GGTGTT) should be excluded, and the sequences
containing a palindrome should also be omitted to avoid unwanted
hairpin structures. By BLAST search, we chose two potential
interference targets for every target mRNA, which did not have
homology to other mouse mRNA sequences. Two cohesive cloning
sites of BbsI were designed at the ends of the forward and reverse
insert template with a loop sequence (TCAAGAG) for cloning into
the RNAi vector—psiRNA-hH1GFPzeo (Invivogen, San Diego, CA,
USA). Table 3 shows the location and sequence of every potential
interference target, and the name of every recombinant RNAi vector.
Table 3 | Location and sequence of the potential interference target site, and the recombinant vector name
Target gene Location of target sitea Sequence of target site Recombinant vector name
NPHS2 54–74 50-GTCCTCCTCTAGGGATGACAA-30 siPod 54
966–986 50-GCTTCGATACTTGCACACTCT-30 siPod 966
NPHS1 492–512 50-GGTAGCTGGACAGGAATATGT-30 siNep 492
1031–1051 50-GAAGCATCACTCTGCAGGTCA-30 siNep 1031
ACTN4 319–339 50-GTGCACAAGATCAACAATGTA-30 siAct 319
1790–1810 50-GGATCGCTGAGAGCAATCACA-30 siAct 1790
CD2AP 21–41 50-GTATGACTATGATGCTGTACA-30 siCda 21
744–764 50-GCCTCTGGGATCTAGAACTCA-30 siCda 744
aAccording to the number from the first base of the start codon of the target mRNA.
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Construct of recombinant RNA interference plasmid
The forward and reverse oligonucleotides were annealed, and the
resulted double strand DNA was ligated into the psiRNA-
hH1GFPzeo digested with BbsI (Invivogen). Then, Escherichia coli
GT116 competent cells (Invivogen) were transformed with the
above ligation products, and spread on E. coli FastMediaTM Zeo Xgal
(Invivogen) plate containing 25 mg/ml zeocin (Invivogen) to take
advantage of the white/blue selection. After confirmed the presence
of the siRNA insert by digesting with SpeI (Invivogen), and further
verified by sequencing with primer OL381 and OL178 (Invivogen),
the recombinant plasmids were prepared with Wizards PureFection
Plasmid DNA Purification System (Promega, Madison, USA), and
quantitated with UV spectrophotomer (UV 2100, Shimadzu, Japan).
Figure 8 shows the schematic drawing of the recombinant siPod 54
vector.
Culture and transfection of podocyte
Conditionally immortalized mouse podocyte clone was a kindly gift
from Dr Mundel,19 and was cultured at 331C in RPMI 1640 medium
(Gibco, Gaithersburg, MD, USA) containing 10% fetal bovine serum
(Gibco), 100 U/ml of penicillin–streptomycin and 10 U/ml of mouse
g-interferon (PEPRO Tech, London, UK). To induce differentiation,
podocytes were reseeded and cultured at 371C in six-well plates with
glass coverslips and 25 cm2-flasks coated with 10mg/ml of type-I
collagen (Sigma, St Louis, MO, USA) by removal of g-interferon.
When they grew to about 60% confluence, podocytes were
transfected with the above-verified recombinant plasmid DNA and
LyoVecTM (Invivogen) according to the manufacturer’s instruction.
Cells were harvested about 48 h after transfection to assay the
activities of target genes. Expression of green flurescence protein
enables the detection of cells transfected with the recombinant RNAi
plasmid.
The vector – psiRNA-hH1GFPzeo was used as the control
plasmid, which cannot produce any hairpin siRNA, then was
expected to have no any interference effect on mouse genes.
Antibodies
The following primary antibodies were used: rabbit polyclonal
antibody against mouse nephrin (a kindly gift from Professor Karl
Tryggvason); rabbit polyclonal antibody against the C-terminal part
of human podocin (a generous gift from Professor Corinne
Antignac); rabbit polyclonal antibody against the C-terminus of
CD2AP of human origin (Santa Cruz, CA, USA); and rabbit
polyclonal antibody against the C-terminus of a-actinin-1 of human
origin, which can react with mouse, rat as well as human a-actinin-1,
-2, -3 and -4 (Santa Cruz).
Tetramethyl rhodamine isothiocyanate-conjugated goat anti-
rabbit IgG (Santa Cruz) was used as the secondary antibody for
immunolabeling. The dye hoechst (Sigma) was used for nuclei
staining.
Immunofluorescence staining
The immunolabeling was carried out as previously described.28,34
Briefly, cells were fixed with ice-cold acetone, then permeabilized
and blocked with 0.3% Triton X-100 and 5% bovine serum albumin
(Sigma) in phosphate-buffered saline. The primary antibodies, the
secondary antibody and hoechst were applied at appropriate
dilutions, and the coverslips were mounted on glass slides with
15% Mowiol. Images were obtained by confocal laser-scanning
microscopy using a Bio-Rad Radiance 2100 TM confocal system,
and processed with Adobe Photoshop 7.0 software.
Semiquantitative RT-PCR
Total RNA extracted with Trizol (Gibco) was reversely transcribed as
previously described.28 The sequence-specific primers for CD2AP
with a size of 191 bp were a forward primer 50-AGCGAATCAG
CACTTATGGA-30 and a reverse primer 50-CCACCAGCCTTCTTC
TACCT-30, and the PCR conditions were as follows: 5 min at 941C
for the initial denaturation, followed by 1 min at 941C, 45 s at 581C
and 1 min at 721C for amplification, and a final extension at 721C
for 5 min. Sequence-specific primers for nephrin, podocin,
a-actinin-4 and GAPDH, and the PCR conditions were previously
described.7 PCR amplification was performed with 32, 30, and 28
cycles, respectively.
The PCR products were separated on agarose gel. For the
quantification, an image of the gel stained with ethidium bromide
was captured, and the intensity of the bands was quantitated using
AlphaImager gel analysis system (Alpha Innotech, San Leandro, CA,
USA). In this study, the semiquantification analysis was performed
using the PCR products of 30 cycles, which existed distinct
difference between KD group and control group.
Protein extraction and Western blotting
Podocyte cells were lysed in a lysis buffer containing 1% Tritonx-
100, 150 mM NaCl, 1 mM EDTA, 50 mM Tris-HCl (pH 7.7), 1 mM
phenylmethylsulfonyl fluoride, 1 mg/ml leupeptin, 1 mg/ml pepstatin
(Sigma) on ice.28,34 An 8% sodium dodecyl sulfate-polyacrylamide
gel was run, loading 75 mg of total protein in each lane. The gel was
set up for transfer to nitrocellulose membranes (Amersham Life
Science, Piscataway, NJ, USA). Then, the membranes were rinsed in
a Tris-buffered saline with 0.02% Tween-20, followed by immersing
in 5% low-fat milk powder. Subsequently, the membranes were
incubated with antinephrin, podocin, CD2AP, a-actinin, or GAPDH
antibodies at appropriate dilutions. Mouse monoclonal antibody
against GAPDH (Chemicon, Temecula, CA, USA) was used in this
study. After rinsing three times, the membranes were incubated with
HRP-conjugated goat anti-rabbit or mouse IgG (Santa Cruz). After
final washing, the membranes were developed using ECL chemilu-
minescence reagent (Santa Cruz) and the specific protein bands were
scanned and quantitated in relation to the GAPDH (36 kDa).
Target sequence (sipod54):
siRNA insert template:
Hairpin siRNA:
psiRNA-hH1 GFP Zeo
(3582 bp)
Hairpin
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Figure 8 | The schematic drawing of the recombinant siPod54
vector, siRNA insert template, and the transcript – hairpin siRNA.
The siRNA insert with a loop sequence (TCAAGAG) and a termination
signal (4A) was cloned between two BbsI sites, immediately down-
stream of a hH1 promoter and upstream of the sequences encoding
green flurescence protein (GFP). The transcript – hairpin siRNA
consists of a sense strand, a loop, and an antisense strand.
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Statistics analysis
In this study, all independent experiments were performed four
times and the values reported are the means7s.d. Statistical
comparisons were performed by using the Mann–Whitney test.
Po0.05 were considered statistically significant.
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